Tag: Pharma

New KRAS Inhibitors Transform Pancreatic Cancer Treatment

April 19, 2026

New KRAS Inhibitors Transform Pancreatic Cancer Treatment

$3.15 Billion Upfront and $1.85 Billion in Performance-Based Payments Agreed

April 8, 2026

$3.15 Billion Upfront and $1.85 Billion in Performance-Based Payments Agreed

March 23, 2026

BörsenNEWS.de Disclaimer – Legal Information & Terms of Use

Retatrutide: Lilly’s New Drug Slashes Weight & Blood Sugar | GLP-1 Advances

March 23, 2026

Retatrutide: Lilly’s New Drug Slashes Weight & Blood Sugar | GLP-1 Advances

Web Analytics